Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Triamcinolone Acetate in Oral Submucous Fibrosis
NCT07914504Not yet recruiting
- Sponsor
- Allama Iqbal Medical College
- Start
- Nov 2026
- Primary completion
- May 2029
- Countries
- 1
01
Overview
Randomised trial of autologous platelet-rich plasma in Oral submucous fibrosis (OSF) (2 arms), sponsored by Allama Iqbal Medical College. Primary endpoints: Maximum Interincisal Distance at 3 months and Cheek Flexibility at 3 months. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Oral submucous fibrosis (OSF)
Beyond the preview
Go deeper on NCT07914504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914504.